StockData
Context Therapeutics Inc. logo

Context Therapeutics Inc. (CNTX) stock

CNTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 6/30
$0.17+0.01 (+3.07%)

Close on Nov 17, 2026Market cap $15.71MP/E –Yield –

Context Therapeutics market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Context Therapeutics's market cap was $19.86M on Nov 11, 2026, against $102.90M a year earlier. Over the last 5 years it ranged from $711.00K to $261.86M, with a median of $32.01M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$19.86M-85.3%
2025Dec 31, 2025$135.06M+71.5%
2024Dec 31, 2024$78.75M+336.5%
2023Dec 29, 2023$18.04M+73.4%
2022Dec 30, 2022$10.41M+1022.3%
2021Dec 31, 2021$927.09K–

More Context Therapeutics figures

See a number that looks wrong?